Immunohistochemistry assay results of LRP6 and Ki-67 expressions in three groups also showed that LRP6 could reverse the inhibited ability of tumor proliferation by miR-137 in vivo (Figure 5F and Figure S3). The gene discussed is MKI67; the disease is neoplasm.